top of page

Currently Enrolling Studies

Vagus Nerve Stimulation (VNS Therapy System) for Treatment-Resistant Depression (TRD)
(Ages 18 years and older) 
Assessing Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-Resistant Depression (TRD) (Ages 18 and older) 
Assessing Efficacy, Safety, and Tolerability of CYB003 as Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) (Ages 18-85)
  Please check back as more study enrollment opportunities will become available!
bottom of page